Barnea Jaffa Lande & Co.'s recent experience includes investments in medical and biotechnology start-ups and emerging companies. The team also covers M&A, compliance, IP, clinical trials, pharmaceutical research, and licensing and collaboration agreements Michael Barnea acts for prominent healthcare and life science companies; Ken Shaked is a former Dexcel Pharma in-house counsel; and Ariella Dreyfuss represents medical device companies, entrepreneurs and investors. Pharmaceutical and healthcare sector specialist Efrat Cohen is a February 2025 recruit.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Michael Barnea is a man to look up to and learn from.’
- ‘They never seem to lose their ambition and passion. Clients view them as true partners and seek their involvement in all critical business and legal decisions.'
- ‘The team possesses vast expertise in various hi-tech and healthcare matters.’
Key clients
- Clexio Biosciences
- MedAware
- BioGenCell
- Maccabi Healthcare Services
- CardiacSense
- Predicta Med
- Tuttnauer
- Lembas
Work highlights
Advising Clexio Biosciences on all commercial matters.
Acting for MedAware, which has developed an AI system to identify medication-related errors and adverse drug events, on commercial matters, including development and licensing agreements.
Advising BioGenCell, a biotechnology company, on its commercial matters.
Practice head
Michael Barnea; Ken Shaked
Other key lawyers
Efrat Cohen; Ariella Dreyfuss; Tal Frelich Hai